Thomas Schuetz

Thomas J.
Schuetz is the founder of Compass Therapeutics LLC, founded in 2014, serving as Manager.
Dr. Schuetz was the founder of Astellas Gene Therapies, Inc., founded in 2012, serving as Independent Director from 2013 to 2020.
Dr. Schuetz is the founder of Compass Therapeutics, Inc., founded in 2014, serving as Vice Chairman, President & CEO since 2024.
Current jobs include Director at Arteaus Therapeutics LLC and Director at GLyPharma Therapeutic, Inc. Former jobs include President, Chief Executive Officer & Director at Olivia Ventures, Inc.; Director at Enobia Pharma, Inc. from 2007 to 2012; Independent Director at Relypsa, Inc. from 2013 to 2016; Vice President-Clinical Affairs at Transkaryotic Therapies, Inc.; Venture Partner at OrbiMed Advisors LLC; Chief Medical Officer at Gelesis, Inc.; Advisor at Limulus Management Co. LLC; Chief Medical Officer at Therion Biologics Corp.
from 2003 to 2006; and Entrepreneur-in-Residence at OrbiMed Advisors Private Equity.
Education includes a doctorate from Harvard University, an undergraduate degree from Xavier University, and a doctorate from Harvard Medical School.